Table I. Clinicopathologic characteristics of the patients in cohort of bladder urothelial carcinomas.

	Bladder urothelial carcinoma (BLCA)		Benign urothelial lesion (BUL)
Gender (%, n)
Male	100%	10/10	100%	10/10
Age at diagnosis (years)
50–60	20%	2/10	30%	3/10
60–70	20%	2/10	10%	1/10
70	60%	6/10	60%	6/10
Pathologic diagnosis
Invasive urothelial carcinoma, high grade	40%	4/10
Papillary urothelial carcinoma, high grade	60%	6/10
Urothelial papilloma			30%	3/10
Cystitis cystica			70%	7/10
Stroma invasion
Present	90%	9/10
Pathologic stage
pTis	10%	1/10
pT1	60%	6/10
pT2	30%	3/10
AJCC stage
0is	10%	1/10
I	60%	6/10
II	30%	3/10
Treatment
Transurethral resection	36%	4/10	100%	10/10
Cystectomy	9%	1/10
Nephroureterectomy	9%	1/10
No treatment	18%	2/10
Adjuvant chemotherapy+cystectomy	9%	1/10
Cystectomy+ureterectomy	9%	1/10
Status
Follow up loss	30%	3/10
No evidence of disease recurrence	30%	3/10	100%	10/10
Local recurrence	30%	3/10
Dead of complication	10%	1/10